MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by intracerebral accumulation of amyloid (Aβ) and abnormally phosphorylated tau, followed by neurodegeneration leading to progressive cognitive decline.